Our findings confirm that minimal expression of AREG/EREG might identify wt KRAS tumours that have a high likelihood of resistance to Ctx and strongly suggest that positive selection for Ctx-resistant tumour cells exhibiting de novo or induced AREG/EREG cross-suppression most likely has an important role in determining the emergence of Ctx resistance. The gene discussed is KRAS; the disease is neoplasm.